Sirtex class action settled
James ThomsonColumnist
Biotechnology company Sirtex has settled a shareholder class action over a profit downgrade in 2016 that caused its shares to plunge.
The settlement came on Thursday evening, almost two weeks into a four-week Federal Court trial before Justice Bernard Murphy.
Loading...
James Thomson is senior Chanticleer columnist based in Melbourne. He was the Companies editor and editor of BRW Magazine. Connect with James on Twitter. Email James at j.thomson@afr.com
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles